Johnson & Johnson company Janssen Research & Development has signed an agreement with Atropos Health to aid in expediting clinical development by leveraging real-world data analysis.

As part of the deal, data researchers from both companies will leverage the software platform of Atropos to assess the real-world data sets of Janssen. 

This approach will aid the companies in obtaining insights into clinical development strategies.

These strategies comprise trial design optimisation, comprehending the natural history of the patients and evaluating outcomes in real-world patients. 

A wide-ranging portfolio of therapeutic fields will be part of the new alliance.

Atropos Health CEO and co-founder Dr Brigham Hyde said: “Atropos Health’s core mission is to close the evidence gap for patients worldwide. 

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We are thrilled to collaborate with Janssen R&D’s world-class data scientists to support efforts to generate insights that could help optimise and accelerate clinical trials.”

Atropos Health focuses on generating evidence for research and clinical purposes using technology. This approach aids in expediting clinical development and cutting down on time to value. 

The company’s Atropos Evidence Platform is leveraged by healthcare companies and life science companies, among others, to bridge the gaps in evidence generation.

This platform also aids enterprises in boosting clinical outcomes and speeding up research activities.

Atropos’ solutions are based on numerous peer-reviewed publications, clinician users, years of clinical usage and expertise.